Archive for October 29th, 2009

Top Winners & Losers After-Hours (CNXT, GNW, LVS, NVTL, TSRA)

Included is the after-hours moves and pertinent data with a snapshot as of 5:14 PM EST.  Estimates are Thomson Reuters data where noted: Conexant Systems, Inc. (NASDAQ: CNXT) closed at $2.44 and shares are trading at $2.88 up 18.03% on 67,400 shares since the closing bell. This one posted 0.11 EPS vs. $0.09 estimates; imaging [...]

HGSI Stock & Options Alert (HGSI)

Human Genome Sciences, Inc.  (NASDAQ: HGSI) has been soaring today.  At 2:45 PM EST we saw this one already cross a full day’s trading volume at 120% normal stock trading volume and that options were picking up throughout the day.  This follows the JPMorgan upgrade to Overweight from Neutral ahead of new additional clinical data.  [...]

FedEx Options Alert (FDX)

FedEx Corporation (NASDAQ: FDX) has seen a very bullish options bet for December in a risk reversal as the trader sells 6,500 $65 puts at $0.975 and buys the same number of $85 calls at $0.95 for a small credit trade.  Shares are looking fairly good on the chart with a $72.50 support level from [...]

Transcept Biggest Loser, Near Cash Value (TSPT)

Transcept Pharmaceuticals, Inc. (NASDAQ: TSPT) is getting destroyed and is today’s largest percentage loser by far.  The FDA did not approve the comjpany’s experimental sleep disorder drug called Intermezzo.  The reason was over safety issues, but the FDA has requested additional data that might require more studies. At 9:00 AM EST we have shares trading [...]

American Superconductor Superhero (AMSC)

American Superconductor Corporation (NASDAQ: AMSC) is not that active yet in the early hours.  Yet.  The company posted increased revenues of 85% to $74.7 million and non-GAAP EPS to $0.19; it generated $35.8 million in cash from operations and it increased its order backlog to $587 million.  The company also raised guidance.  Shares closed at [...]

First Solar in the Trader Shade (FSLR)

First Solar Inc. (NASDAQ: FSLR) is ugly this morning, but not as ugly as it was last night.   The earnings beat was marginal and the revenues were very soft because they did not include a project revenue target that was deferred.  The guidance is still only in-line for Q4 and the company issued some [...]